Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Jan 31, 2023 9:23am
203 Views
Post# 35256302

RE:RE:Open invitation

RE:RE:Open invitation

the whole thing is a joke.

Any investor needs to just look at the last 3 years of presentations and see that nearly every projection was wrong. Very little was accomplished and a lot of money was spent on salaries.

Sure, baxter gave them a pittance.. which is all these pumpers talk about.. because they pretend to be wowed and amazed at this paltry sum of money... but they've spent 8x that on salaries alone ($40M +) all while the share price stayed the same or went slightly down..  because the one and only thing that matters, trial enrolment, is as terrible today as it was 3 years ago... 1 patient per month.

Everything else is just noise intended to distract from the abysmal failure that is this managements entitlement rate. 

Here's a funny one for MM.. Baxter, a multibillion dollar and multinational company, bought $5M in equity and $2.5M in convertible debt for a gamble at a potential product for their pipeline (of which they have hundreds)... but paradigm, a relatively small Canadian investment dealer, brought in $40M from the savings of high net worth individuals and local family offices. 


Keep in mind a single marketing campaign for a pharmacy company can reach north of $500M. 

https://www.latimes.com/science/sciencenow/la-sci-sn-medical-marketing-money-20190109-story.html

Sure, they think the product has promise, as does everyone on this board including me, but that does not guarantee success and from the outside looking in... at this enrolment rate... the most profitable thing to date has been the lifestyle executives live. At one point paying $750 000 per year in executive compensation to just the CEO. For 20 years? Give or take a year or two or $100 000 in some years. 
 


Stocktree wrote:
Simply put, no one would be coming here to complain about pumping posters if pumping posters didn't make it their job to lure people into thinking the last failure is nothing and all potential future successes are a near certainty.

Tell MM and his mob to stop posting and I will stop posting, to the same degree.

And I BB on a stock is not supposed to be an ad for the stock, don't you think?

Thank you for your time.

 

<< Previous
Bullboard Posts
Next >>